0.72

4.00% 0.0277

Allurion Technologies Inc (ALUR)

Overview News Price History Option Chain Discussions Forecast

Allurion Technologies Inc stock is traded at $0.72, with a volume of 51,258. It is up +4.00% in the last 24 hours and up +2.13% over the past month. Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Previous Close:

$0.6923

Open:

$0.68

24h Volume:

51,258

Relative Volume:

0.30

Market Cap:

$44.50M

Revenue:

$64.42M

Net Income/Loss:

$-73.78M

P/E Ratio:

EPS:

Net Cash Flow:

$-60.50M

1W Performance:

-6.43%

1M Performance:

+2.13%

6M Performance:

-68.70%

1Y Performance:

-84.07%

1-Day Range:

$0.68

$0.7329

1-Week Range:

$0.68

$0.7876

52-Week Range:

$0.5535

$4.64

Allurion Technologies Inc Stock (ALUR) Company Profile

Name

Allurion Technologies Inc

Sector

Healthcare (1181)

Industry

Medical Devices (155)

Phone

508-647-4000

Address

11 HURON DR STE 200, NATICK

Employee

Twitter

Next Earnings Date

2024-11-13

Latest SEC Filings

ALUR's Discussions on Twitter

Allurion Technologies Inc Stock (ALUR) Latest News

Nov 04, 2024

Allurion reports significant weight loss in global patient study By Investing.com - Investing.com Australia

Nov 04, 2024

Allurion reports significant weight loss in global patient study - Investing.com

Nov 04, 2024

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference - Business Wire

Nov 04, 2024

Oct 30, 2024

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024 - Marketscreener.com

Oct 30, 2024

Oct 29, 2024

Allurion sets date for first annual stockholders meeting By Investing.com - Investing.com Canada

Oct 29, 2024

Oct 28, 2024

Allurion sets date for first annual stockholders meeting - Investing.com

Oct 28, 2024

Allurion Technologies : Proxy Statement Form 8 K - Marketscreener.com

Oct 28, 2024

Oct 26, 2024

Allurion Technologies, Inc. Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com

Oct 26, 2024

Oct 24, 2024

RTW INVESTMENTS, LP Reduces Stake in Allurion Technologies Inc - GuruFocus.com

Oct 24, 2024

ALUR Stock Declines Despite Submitting PMA for Allurion Balloon - Yahoo Finance

Oct 24, 2024

Allurion Technologies (NYSE:ALUR) Shares Down 3.8% – Time to Sell? - Defense World

Oct 24, 2024

Oct 23, 2024

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com

Oct 23, 2024

Oct 09, 2024

Allurion reports weight loss success with gastric balloon By Investing.com - Investing.com South Africa

Oct 09, 2024

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - Benzinga

Oct 09, 2024

Allurion’s swallowable balloon hits trial success amid weakening financials - Yahoo! Voices

Oct 09, 2024

Allurion reports weight loss success with gastric balloon - Investing.com India

Oct 09, 2024

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss - Marketscreener.com

Oct 09, 2024

Oct 04, 2024